Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
$879M |
| 2 |
Netflix
NFLX
|
$855M |
| 3 |
T-Mobile US
TMUS
|
$703M |
| 4 |
Alcon
ALC
|
$457M |
| 5 |
Intuitive Surgical
ISRG
|
$327M |
Top Sells
| 1 |
Tesla
TSLA
|
$1.32B |
| 2 |
Salesforce
CRM
|
$808M |
| 3 |
CrowdStrike
CRWD
|
$503M |
| 4 |
Apple
AAPL
|
$493M |
| 5 |
Estee Lauder
EL
|
$350M |
Sector Composition
| 1 | Technology | 25.75% |
| 2 | Healthcare | 20.44% |
| 3 | Consumer Discretionary | 17.04% |
| 4 | Financials | 10.94% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vaxcyte
PCVX
$4B
| $68.2M | 0.07% | +1,422,007 | New | +$68.2M |
|
152
Kirby Corp
KEX
$5.42B
| $67.1M | 0.07% | 1,042,696 +404,845 | +63% | +$26.1M |
|
153
Paycom
PAYC
$12.8B
| $65.2M | 0.07% | 210,216 +83,177 | +65% | +$25.8M |
|
154
Littelfuse
LFUS
$6.44B
| $64.5M | 0.07% | 292,951 -106,807 | -27% | -$23.5M |
|
155
Enterprise Financial Services Corp
EFSC
$2.27B
| $63.7M | 0.06% | 1,301,703 +217,302 | +20% | +$10.6M |
|
156
Halliburton
HAL
$19.4B
| $63.3M | 0.06% | 1,608,804 +172,287 | +12% | +$6.78M |
|
157
Agilent Technologies
A
$35.7B
| $63.3M | 0.06% | 422,690 -208,088 | -33% | -$31.1M |
|
158
Huron Consulting
HURN
$2.37B
| $62.2M | 0.06% | 857,406 -1,040 | -0.1% | -$75.5K |
|
159
Envista
NVST
$3.52B
| $62.2M | 0.06% | 1,847,410 -621,377 | -25% | -$20.9M |
|
160
BioMarin Pharmaceuticals
BMRN
$11.2B
| $59.9M | 0.06% | 578,623 +15,117 | +3% | +$1.56M |
|
161
AES
AES
$9.64B
| $59.9M | 0.06% | 2,081,516 +653,932 | +46% | +$18.8M |
|
|
HZNP
162
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $59.6M | 0.06% | 523,678 -1,217,432 | -70% | -$139M |
|
163
Bloomin' Brands
BLMN
$625M
| $59.6M | 0.06% | 2,959,829 +32,543 | +1% | +$655K |
|
164
Alexandria Real Estate Equities
ARE
$14.1B
| $59.1M | 0.06% | 405,836 +960 | +0.2% | +$140K |
|
165
e.l.f. Beauty
ELF
$7.09B
| $59.1M | 0.06% | 1,067,829 -339,531 | -24% | -$18.8M |
|
166
Independence Realty Trust
IRT
$4.23B
| $58.8M | 0.06% | 3,485,887 +39,912 | +1% | +$673K |
|
167
Syndax Pharmaceuticals
SNDX
$1.41B
| $58.6M | 0.06% | 2,302,246 +652,451 | +40% | +$16.6M |
|
168
Lowe's Companies
LOW
$145B
| $57.9M | 0.06% | 290,658 -92,749 | -24% | -$18.5M |
|
|
ROIC
169
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $57.7M | 0.06% | 3,840,284 -28,754 | -0.7% | -$432K |
|
170
Brunswick
BC
$4.15B
| $57.4M | 0.06% | 797,001 -11,197 | -1% | -$807K |
|
171
Universal Display
OLED
$6.59B
| $55.5M | 0.06% | 513,311 +137,408 | +37% | +$14.8M |
|
172
Cactus
WHD
$2.88B
| $55.3M | 0.06% | 1,100,602 -26,728 | -2% | -$1.34M |
|
173
Blackstone
BX
$134B
| $54.9M | 0.06% | 740,371 -114,136 | -13% | -$8.47M |
|
174
CONMED
CNMD
$1.68B
| $54.9M | 0.06% | 619,336 +113,530 | +22% | +$10.1M |
|
175
Ferrari
RACE
$85B
| $54.6M | 0.06% | 254,695 +394 | +0.2% | +$84.4K |
|